Clinical Trial Update: RIC-NEC Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial named RIC-NEC for necrotizing enterocolitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Necrotizing Enterocolitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING